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INTRODUCTION
The goal of muscle hypertrophy can be attained through proper diet 
and appropriate exercise. Muscular contractions induced by moder-
ate to intense resistance training have been shown to increase ana-
bolic muscle signaling (P70s6k, mTOR), and when performed 
chronically, often leads to muscle hypertrophy [1]. With the use of 
dietary supplementation (protein) it is possible to increase the rate 
of muscle hypertrophy [30,31]. Branched chain amino acids (BCAA) 
supplementation has been shown to increase muscle protein anab-
olism [4], with leucine, a component of whey protein, being the most 
anabolic BCAA [35].
Leucine is one of the essential amino acids in the diet. It is ca-
pable, like all branched chain amino acids, of avoiding hepatic al-
terations due to the lack of L-branched chain aminotransferase in 
the liver [22]. Leucine enters muscle cells through the L type amino 
acid transporters [19,14], where it helps activate, via phosphoryla-
tion, mTOR by binding to nutrient sensitive molecules such as hVps34 
and leucyl-tRNA synthetase [15]. Once this has occurred, mTOR 
then phosphorylates P70s6k and 4E-BP1. P70s6k in turn phos-
phorylates rpS6 which is a ribosomal protein specific to anabolic 
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protein synthesis in myotubes. When 4E-BP1 is phosphorylated, it 
releases EIF4 which can interact with mRNA transcription. This 
activation in turn causes an anabolic response by activating RNA 
translation factors which leads to increased protein synthesis [21]. 
Increased activation of this pathway has been shown to lead to 
greater hypertrophy over time [1].
Leucine also stimulates insulin release from pancreatic beta cells 
by activating glutamate dehydrogenase (GDH) and AKT, which in 
turn lead to insulin release [33]. Leucine itself is associated with 
anabolic signaling in skeletal muscle [5] by interacting with IGF 
receptors that activate PI3K and thereby activates AKT in the mus-
cle. Once AKT is activated it can also cause the phosphorylation of 
mTOR [26]. Furthermore, resistance training and leucine supple-
mentation can possibly increase the release of insulin-like growth 
factor 1 (IGF1) in the body [12,24].
With resistance training alone there is a transient increase in 
muscle protein anabolism markers [30], but with protein supple-
mentation (often whey) this activation is further increased [9, 17]. 
However, the amount of activation that occurs due to supplementa-
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(8 ounces) of fluid. Blood samples were collected 30-45 minutes 
post-ingestion and muscle biopsies were taken 45-60 minutes post 
ingestion.
Supplement and placebo composition
The whey protein (10 g) plus leucine (10 g) supplement included 
2 g of carbohydrates, and no other nutritive additives. The placebo 
supplement contained 4 g of carbohydrates and no other nutritive 
additives. Both of these compounds were independently tested for 
purity and composition validation (Covance Laboratories Inc., 
Madison, WI).
Blood Sampling and Analyses
Blood samples from an antecubital vein were collected in 10 mL 
vacutainers with appropriate additives (no additives [serum] or so-
dium fluoride/potassium oxalate). Serum aliquots were frozen 
at -80˚C until assayed in duplicate with enzyme-linked immunosor-
bent assay (ELISA) kits for insulin, cortisol (Alpco Diagnostics, Salem, 
NH), and glucose (Arbor Assays, Ann Arbor, MI). Respective intra- 
and inter-assay variances were cortisol (CV=3.1% & 5.5%), insulin 
(CV=4.3% & 2.3%), and glucose (CV=4.7% & 4.6%).
Muscle Biopsies
Biopsies, using a Bergstrom needle (Bignel Surgical Inc., Essex, 
United Kingdom) with the double-chop technique [27] and suc-
tion [11], were obtained from the mid-belly of the vastus lateralis 
muscle, with subsequent biopsies 2-3 cm superior or inferior to the 
initial biopsy site. Samples were immediately frozen in liquid nitrogen 
(-159˚ C) and stored in a liquid nitrogen cooled storage tank until 
analyzed.
Muscle Protein Analysis
Portions of the muscle samples weighing 15.8±6.0 mg were ex-
tracted (10 μL·mg tissue-1; 44 mL Tris HCl, 4 mL glycerol, 2.5 mL 
β-mercaptoethanol, 368 mM SDS), with protease and phosphatase 
inhibitors and PMSF (phenylmethanesulfonyl fluoride; Halt Inhibitor 
Cocktail, Thermo Scientific Inc., Rockford, IL) were added to the 
extraction buffer 1:100. Samples were homogenized for 
30s x 30,000 RPM in glass test tubes, and aliquoted into two vials 
for each analysis. Prior to analysis, the vials were centrifuged at 
16,000 g for 20 minutes at 4˚C, with the supernatant collected for 
western blot analysis. Protein concentrations were assayed using a 
micro Lowry method with Peterson’s modification (Sigma Aldrich, 
Saint Louis, MO). Proteins were separated via SDS-PAGE using 4-15% 
gradient gels at a constant current of 0.05 A, and then transferred 
to PVDF membranes.
Infra-red Labelled Secondary Antibodies
Primary monoclonal antibodies for both total and phosphorylated 
signaling proteins were applied for mTOR and AKT (R&D Systems, 
Minneapolis, MN), and for P70s6k, 4E-BP1, and rpS6 (Cell Signal-
tion, specifically leucine, has not been well studied in humans, and 
there have been conflicting results on the amount of signaling that 
occurs. In general, it seems to have an additive effect, and it is rela-
tively easy to saturate the signaling pathway via leucine supplemen-
tation [17]. In the rat model, saturation occurs at 0.675g of leucine 
per kg of bodyweight when applied as a bolus [34]. However, in 
humans, the exact amount has yet to be established, but suggestions 
for transient saturation are single doses of at least 1.8 grams, but 
this has not been fully investigated [13]. Furthermore, there is a lack 
of research showing a large training stimulus effect on muscle protein 
phosphorylation in conjunction with protein supplementation.
The purpose of this study was to analyze the effects of leucine-
enriched whey protein supplementation on muscle anabolic signaling 
protein phosphorylation in healthy, resistance-trained males. Addi-
tionally, differences in insulin concentrations between leucine-enriched 
whey protein supplementation and a low-carbohydrate placebo was 
assessed.
MATERIALS AND METHODS 
Subjects
Twenty healthy, recreationally resistance-trained men (2-10 hrs·wk-1) 
who were not consuming any nutritional supplements or prescription 
drugs (mean±SD; age = 27.8±2.8 years, height = 1.78±0.07 m, 
weight = 81.3±11.0 kg) provided informed consent as approved 
by the institution’s Human Subjects Committee to participate in this 
study.
Study Design
A randomized cross-over study design was conducted that involved 
three visits [13,16] and replicated previous research on muscle 
signaling pathways [17]. Visit 1 included baseline data collection, 
while visits 2 (3-7 d later) and 3 (5-9 days after visit 2) were ex-
perimental visits where either the supplement or placebo was ran-
domly administered. The time of day for all visits was held constant 
(0900 – 1300 hrs) for each subject to avoid diurnal hormonal vari-
ations [31].
Baseline Session
Following a 12 hr overnight fast, both a blood sample and muscle 
biopsy were collected, followed by a 10 repetition maximum (10 RM) 
test on a 45˚ plate loaded leg press machine and a selectorized leg 
extension machine [2].
Experimental Sessions
For both sessions, subjects arrived fasted, confirmed abstention from 
physical training for the previous 48 hours, and performed 5 sets of 
10 repetitions at their previously tested 10 RM for both the leg press 
and leg extension exercises, with 2-minute inter-set rest intervals. If 
a subject failed to achieve all 10 repetitions, the load was decreased 
by 4.5 kg for the following set. Immediately post-exercise, in random-
ized order, subjects ingested the supplement or placebo in 236.5 ml 
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ing, Danvers, MA). Phospho-specific anti-rabbit secondary antibod-
ies for mTOR (S2448) and AKT (S473, S474, S472), and anti-mouse 
(AKT) or anti-goat (mTOR) antibodies for total protein (Rockland, 
Gilbertsville PA) were used prior to imaging with an infra-red detec-
tion system (Li-Cor Biosciences Inc., Lincoln, NE). Both total and 
phosphorylated protein infrared light concentrations were quantified 
at the same time since the secondary antibodies for total (700 nm) 
and phosphorylated (800 nm) proteins were visible at different wave-
lengths.
Chemiluminescent Secondary Antibodies
Phospho-specific anti-rabbit primary antibodies for P70s6k (Thr 421, 
S424), rpS6 (S235, S236), and 4E-BP1 (S65) (Cell Signaling, Dan-
vers, MA) were visualized using chemiluminescent-labelled second-
ary antibodies (Amersham ECL Prime Western Blot Detector, GE 
Healthcare and Life Sciences, Pittsburgh, PA), and imaged with a 
Fluorchem SP system (Protein Simple Inc. Santa Clara, CA). Blots 
were then stripped for 20 minutes (glycine 15g, SDS 1g, Tween 20 
10mL, QS ultra-pure water 1L, pH 2.2) before being reimaged to 
verify removal of all secondary and primary antibodies. Blots were 
then reprobed for total content of P70s6k, rps6, and 4E-BP1 (Cell 
Signaling, Danvers, MA).
Western Blot Quantification
All samples for each subject were analyzed in the same blot, and all 
bands were quantified 3 times per individual with the mean value 
utilized for statistical analyses. The phosphorylated to total protein 
Fig. 1. Akt phosphorylated to total protein ratio normalized values 
to baseline session values (X±SD). There were significantly greater 
levels of phosphorylation for the supplement condition over both the 
placebo (+) and baseline visit (*) (p<.05).
Fig. 2. mTOR phosphorylated to total protein ratio normalized values 
to baseline session values (X±SD). There was no significant change 
in levels of phosphorylation between any visit (p>.05).
signal ratio was normalized to baseline for statistical comparisons. 
Due to insufficient samples for some subjects, analysis of protein 
was only performed on 17 subjects. Examples of representative pro-
tein luminescence and infrared concentration images are shown in 
each protein figure (Figures 1-5).
Dietary Records
Dietary intake was analyzed for the day prior to each visit using Diet 
Analysis Plus software, Version 10 (Cengage Learning, Inc. 2012). 
All analyses were performed by the same individual.
Statistical Analysis
Individual protein phosphorylation ratios (phosphorylated:total pro-
tein; arbitrary units) were normalized to a value of “1” for each 
subject’s baseline measurement. Supplement and placebo condition 
ratios were reported relative to each subject’s baseline ratio. All 
descriptive and performance data (X±SD) for the exercise sessions, 
as well as the ratios of phosphorylation to total protein of the signal-
ing pathway proteins, and the blood variables were compared using 
one-factor repeated measures analyses of variance (ANOVAs) with 
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on the leg extension machine was 67.5±9.6 kg with a decrease of 
17% over the course of the 5 sets. Overall, this gave an average 
ratio body-weight-to-leg-press-weight of 2.76, and for the leg exten-
sion exercise this ratio was 0.83. The total amount of work for both 
lifting sessions, as measured by volume-load (repetitions x weight), 
was 10561±927 kg for the leg press and 2975±119 kg for the leg 
extension. There was no significant difference in weight lifted or 
relative fatigue for either testing condition for both exercises (p=0.99, 
0.17 respectively). Relative fatigue was measured by the initial load 
on the movement compared to the final load performed in a given 
exercise.
Blood Analyses
Supplementation following resistance exercise increased insulin con-
centrations significantly over the other conditions (F [2, 18] = 24.139; 
p<0.001) (p<0.001 to baseline and placebo conditions), whereas 
the placebo condition exhibited no significant response over the base-
line measurement (p=0.716). Neither glucose (F [2, 18] = 1.534, 
p=0.243) nor cortisol (F [2, 18] = 0.610, p=0.554) concentrations 
changed for the supplemented or placebo conditions (Table 1).
Fig. 3. p70s6k phosphorylated to total protein ratio normalized values 
to baseline session values (X±SD). Both the supplement and placebo 
conditions were significantly greater than the baseline session (*) 
(p<.05).
Fig. 4. 4E-BP1 phosphorylated to total protein ratio normalized val-
ues to baseline session values (X±SD). There was no significant 
change in levels of phosphorylation between any visit (p>.05).
Fig. 5. rpS6 phosphorylated to total protein ratio normalized values 
to baseline session values (X±SD). Both the supplement and placebo 
conditions were significantly greater than the baseline session (*) 
(p<.05). The supplement session was significantly greater than the 
placebo condition (+) (p<.05).
Table 1. Concentrations for each blood variable (X±SD). 
  Baseline Supplement Placebo
Insulin (μIU×ml-1) 15.4±17.3 85.6±69.9* 22.5±29.2
Cortisol (nmol×L-1) 471.7±176.0 495.8±221.7 517.3±201.7
Glucose (mg×dL-1) 2.6±1.0 2.6±0.7 2.9±0.7
* p<.05, different than baseline and placebo
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Muscle Protein Analysis
Acute resistance exercise with leucine and whey supplementation 
increased AKT (F [2, 15] = 9.176, p=0.002) (p=0.003 from base-
line and p=0.012 from placebo) and rpS6 (F [2, 15] =11.102, 
p=0.001) (p=0.001 from baseline and p=0.034 from placebo) 
phosphorylation level significantly over the other sample points 
(Figures 1 and 5). Phosphorylation of p70s6k (F [2, 15] = 10.343, 
p=0.002) increased similarly after resistance exercise for both the 
supplemented (p=0.003) and placebo conditions (p=0.001) 
(see Figure 3). Neither acute resistance exercise nor supplementation 
resulted in changes in phosphorylation of mTOR (F [2, 15] = 0.162, 
p=0.85) or 4E-BP1 (F [2, 15] = 1.522, p=0.232) (Figures 2 
and 4).
Dietary Records
Dietary intake did not change at any time during the study (mean 
daily calories = 2516.9±852.1 kcal·d-1; relative daily calories = 
31.0±10.5 kcal·kg-1·d-1; total protein = 120.1±41.9 grams·d-1; 
relative daily protein intake = 20.2±7.3%.
DISCUSSION  
This study indicates that following heavy resistance exercise, dietary 
supplementation with leucine-enriched whey protein enhanced ana-
bolic signaling in muscle via mTOR signaling pathway and insulin. 
There was a large increase in circulating insulin concentrations after 
ingesting the supplement compared to both the resting and placebo 
conditions, similar to what has been previously reported [33]. Such 
an increase in insulin levels may be helpful for some populations due 
to insulin’s anabolic effect on skeletal muscle [5]. Despite the in-
creased insulin, no differences in blood glucose were observed, most 
likely due to the small amount of carbohydrate (4 grams) in the 
placebo and the lack of carbohydrate in the supplement.
There were no differences in cortisol concentrations, and observed 
values were typical of an individual after waking [18]. Even though 
there was considerable physical and physiological stress from the 
weight-training stimulus, there was no increase in cortisol from base-
line. It is possible there was an anticipatory response during the 
baseline condition from anxiety for the biopsy and other tests to be 
performed [8], although the concentrations observed were within 
normal resting ranges. Since the mechanical work performed during 
both training sessions was nearly equal, similar cortisol responses 
would be expected. Cortisol reactivity is attenuated in well-trained 
compared to untrained individuals [6, 19], although McMillan 
et al. [19] used a greater volume of resistance exercise at approxi-
mately the same relative intensity. The present study used subjects 
that were resistance-trained, which may partly explain the lack of a 
cortisol response to the exercise stimulus. We do acknowledge that 
the post-exercise sampling schedule may not have captured the 
cortisol stress response, since cortisol levels decline after training 
bouts [18].
The majority of intramuscular signal activation over baseline was 
downstream from mTOR. This may be due to the short time course 
of response for the various steps in anabolic signaling after exer-
cise [5], and the rapid uptake of ingested leucine into the blood 
stream [26,18,25,7]. Compared to baseline activity there was sig-
nificant activation of a number of signaling proteins during both the 
supplement and placebo trials. Phosphorylation of AKT for the sup-
plement condition was significantly greater than the placebo and 
baseline conditions, which may have been caused by the greater 
insulin concentrations following supplement ingestion compared to 
the placebo condition. This increased AKT phosphorylation could 
lead to more phosphorylation of mTOR which enhances muscle 
protein synthesis [14, 28]. Similar results have been previously re-
ported with BCAA supplementation after physical exercise [4], al-
though an increase in AKT phosphorylation independent of supple-
mentation has also been reported [23]. Previously, this has been 
interpreted to be a lack of insulin response or supplement application 
even with moderate resistance training volumes [30] when compared 
to the research by Blomstrand et al [4].








↑ = significant change relative to baseline
↑↑ = significant change relative to baseline and placebo
↔ = no change relative to baseline
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the timing of the biopsy was a confounding factor for determining 
4E-BP1 activation. Regardless, Moore et al. [20] reported results 
that were similar to the present study, where there was an enhanced 
activation of rpS6 but not a significant increase in activation 
of 4E-BP1.
The results of the present study found moderate effects of leucine 
ingestion on phosphorylation for some proteins, but not others. This 
could perhaps be due to the slower time course of activation due to 
insulin activation of PI3K which in turn activated AKT, but not sub-
sequently mTOR. The activation of p70s6k and rpS6 which are both 
further down the mTOR signaling pathway and are activated by mTOR 
suggests that mTOR had been activated prior to when the biopsy 
was taken in the present study. Since BCAAs are quickly digested 
and released into the blood stream [26], their effect could have 
contributed to a large and rapid anabolic response. Some studies 
have shown activation of mTOR at one hour and two hours post 
resistance training [3,4] (and other parts of the pathway [9,29]), 
and even at thirty minutes [16,23], with lower intensities or volumes 
of training [10,29].
CONCLUSIONS 
The results of the present study demonstrated that dietary supple-
mentation with whey and leucine in conjunction with a stressful 
resistance exercise session leads to an anabolic hormonal response 
and increased intramuscular protein signaling pathway phosphoryla-
tion for muscle hypertrophy (Table 2). The supplementation of leucine 
led to a much greater insulin response with no differences in cortisol 
or glucose levels. More research analyzing the time course of intra-
muscular protein phosphorylation when leucine supplementation is 
utilized needs to be performed. Finally, individuals seeking to increase 
the acute muscular hypertrophy response to resistance training may 
benefit from supplementing with leucine-enriched whey.
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There was no significant increase of phosphorylation of mTOR 
after either condition during the present study. There was consider-
able variation as indicated by the standard deviation for each time 
point in the study, but the means of the normalized activation did 
not significantly change. This is an interesting result since previous 
studies [3,4,23] have reported a positive effect for BCAA supple-
mentation on mTOR activation. Our results could be influenced by 
the biopsy time point, since Blomstrand et al [4] performed the bi-
opsy at one hour and two hours post-exercise where the greatest 
mTOR phosphorylation was observed at one hour with no change 
immediately after exercise.
For p70s6k, there was increased phosphorylation in the supple-
ment and placebo conditions over the baseline, with similar re-
sponses for both conditions. This suggests that the acute exercise 
bout the subjects performed led to greater p70s6k activation, but 
with no greater effect due to supplementation, activation of this 
protein in a training bout has been related to increases in muscle 
size [28]. The result of the present study is different than other re-
search [17], but the present exercise protocol did have a greater 
amount of resistance training volume that might have generated such 
a large amount of p70s6k phosphorylation that the difference the 
supplement made was not significant.
Ribosomal protein S6 (rpS6) showed the greatest amount of phos-
phorylation for both conditions, and a much greater amount of phos-
phorylation in the supplement condition compared to the placebo 
condition. This magnitude of phosphorylation suggested that there 
was an increase in mRNA synthesis. This is similar to the results 
reported by Karlsson et al, where after a lower volume of training 
than used in the present study, ingested BCAA resulted in greater 
rpS6 activation than either placebo or control visits [17]. Other re-
search has shown an increase in activation directly after exercise 
with supplementation and for an hour thereafter [10].
Both the supplement and placebo conditions exhibited increases 
from baseline for phosphorylation of 4E-BP1. It should be noted 
that, as with mTOR, there was considerable variability in the results, 
perhaps contributing to the lack of statistical significance between 
the conditions. Previous research [15] has also shown activation of 
both rpS6 and 4E-BP1 at the same chronological point with leucine 
supplementation, while other research [10] has shown this same 
effect, but at two hours post-resistance exercise. It is possible that 
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